Advanced Blood & Marrow Transplant Surgeries Across NJ

Our Blood and Marrow Transplant Program is conducted in conjunction with the Rutgers Cancer Institute of New Jersey. The physician and medical teams that focus on blood and marrow transplants perform stem cell transplants for patients with a variety of illnesses, including acute and chronic leukemias, myelodysplasia, various types of lymphoma, Hodgkin's disease, multiple myeloma, amyloidosis and related diseases.

When it comes to stem cell transplants, both autologous and allogeneic transplants are performed. Autologous transplants are when cells are harvested from the patient's bone marrow before chemotherapy and are replaced after cancer treatment. And allogeneic transplants are when stem cells come from a donor whose tissue most closely matches the patient, like a child, sibling or parent. Additional sources of transplant include matched unrelated donors and umbilical cord blood.

With this program, patients have access to clinical trials, state-of-the art technology, disease specific specialists—including the area’s best hematologic pathologists—and a full line of support services: social workers, dieticians, support groups, on-site pharmacy, and financial counselors.

The sources of transplant include matched siblings as well as matched unrelated donors and umbilical cord blood. There are several research initiatives within the our Blood and Marrow Transplant Program. In addition to participating in national and international clinical research studies with other transplant centers, there are unique research programs focusing on novel ways to: prevent graft-versus-host disease; improve umbilical cord blood transplants; and develop novel cellular therapies with less toxicity than standard transplants. The program is certified by FACT as well as the National Marrow Donor Program.